SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-17-000032
Filing Date
2017-07-24
Accepted
2017-07-24 07:04:13
Documents
14
Period of Report
2017-07-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca_7-24x2017x8k.htm 8-K 28205
2 EXHIBIT 99.1 ex991_prx7-24x2017.htm EX-99.1 49692
3 EXHIBIT 99.2 ex992phase2b12moinvesd61.htm EX-99.2 10347
4 ex992phase2b12moinvesd61001.jpg GRAPHIC 112696
5 ex992phase2b12moinvesd61002.jpg GRAPHIC 233248
6 ex992phase2b12moinvesd61003.jpg GRAPHIC 94574
7 ex992phase2b12moinvesd61004.jpg GRAPHIC 117448
8 ex992phase2b12moinvesd61005.jpg GRAPHIC 151391
9 ex992phase2b12moinvesd61006.jpg GRAPHIC 177500
10 ex992phase2b12moinvesd61007.jpg GRAPHIC 101271
11 ex992phase2b12moinvesd61008.jpg GRAPHIC 132791
12 ex992phase2b12moinvesd61009.jpg GRAPHIC 57626
13 ex992phase2b12moinvesd61010.jpg GRAPHIC 98327
14 gncalogoa04.jpg GRAPHIC 9090
  Complete submission text file 0001457612-17-000032.txt   1849824
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 17977524
SIC: 2836 Biological Products, (No Diagnostic Substances)